{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:56:32Z","timestamp":1791410192055,"version":"4.3.3"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The risk of developing micro- and macrovascular complications is higher for individuals with type 1 diabetes (T1D). Numerous studies have indicated variations in gut microbial composition between healthy individuals and those with T1D. These changes in the gut ecosystem may lead to inflammation, modifications in intestinal permeability, and alterations in metabolites. Such effects can collectively impact the metabolic regulation system, thereby influencing blood glucose control. This review aims to explore the relationship between the gut microbiome, inflammation, and blood glucose parameters in patients with T1D.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Google Scholar, PubMed, and Web of Science were systematically searched from 2003 to 2023 using the following keywords: \u201cgut microbiota,\u201d \u201cgut microbiome,\u201d \u201cbacteria,\u201d \u201cT1D,\u201d \u201ctype 1 diabetes,\u201d \u201cautoimmune diabetes,\u201d \u201cglycemic control,\u201d \u201cglucose control,\u201d \u201cHbA1c,\u201d \u201cinflammation,\u201d \u201cinflammatory,\u201d and \u201ccytokine.\u201d The examination has shown 18,680 articles with relevant keywords. After the exclusion of irrelevant articles, seven observational papers showed a distinct gut microbial signature in T1D patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This review shows that, in T1D patients, HbA1c level was negatively correlated with abundance of <jats:italic>Prevotella<\/jats:italic>, <jats:italic>Faecalibacterium<\/jats:italic>, and <jats:italic>Ruminococcaceae<\/jats:italic> and positively correlated with abundance of <jats:italic>Dorea formicigenerans<\/jats:italic>, <jats:italic>Bacteroidetes<\/jats:italic>, <jats:italic>Lactobacillales<\/jats:italic>, and <jats:italic>Bacteriodes<\/jats:italic>. Instead, <jats:italic>Bifidobacteria<\/jats:italic> was negatively correlated with fasting blood glucose. In addition, there was a positive correlation between <jats:italic>Clostridiaceae<\/jats:italic> and time in range. Furthermore, a positive correlation between inflammatory parameters and gut dysbiosis was revealed in T1D patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We draw the conclusion that the gut microbiome profiles of T1D patients and healthy controls differ. Patients with T1D may experience leaky gut, bacterial translocation, inflammation, and poor glucose management due to microbiome dysbiosis. Direct manipulation of the gut microbiome in humans and its effects on gut permeability and glycemic control, however, have not been thoroughly investigated. Future research should therefore thoroughly examine other potential pathophysiological mechanisms in larger studies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1265696","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T08:13:36Z","timestamp":1700036016000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Gut microbiome and blood glucose control in type 1 diabetes: a systematic review"],"prefix":"10.3389","volume":"14","author":[{"given":"Jumana","family":"Abuqwider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Scid\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Lupoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Costabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Mauriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutgarda","family":"Bozzetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2012.12.001","article-title":"The role of the intestinal microbiota in type 1 diabetes","volume":"146","author":"Hara","year":"2013","journal-title":"Clin Immunol"},{"key":"B2","volume-title":"International Diabetes Federation Atlas","year":"2017"},{"key":"B3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/bmj.l4185","article-title":"Prevalence, severity, and nature of preventable patient harm across medical care settings: Systematicreview and meta-analysis","author":"Panagioti","year":"2019","journal-title":"BMJ"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1847","article-title":"Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes","volume":"64","author":"Alkanani","year":"2015","journal-title":"Diabetes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"343ra81","DOI":"10.1126\/scitranslmed.aad0917","article-title":"Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability","volume":"8","author":"Yassour","year":"2016","journal-title":"Sci Trans Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11892-017-0933-9","article-title":"Modulation of type 1 diabetes risk by the intestinal microbiome","volume":"17","author":"Knip","year":"2017","journal-title":"Curr Diabetes Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00678","article-title":"Bacteroides Dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes","volume":"5","author":"Davis-Richardson","year":"2014","journal-title":"Front Microbiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0526","article-title":"Fecal microbiota composition differs between children with \u03b2-cell autoimmunity and those without","volume":"62","author":"de Goffau","year":"2013","journal-title":"Diabetes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025792","article-title":"Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes","volume":"6","author":"Brown","year":"2011","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2015.1011876","article-title":"Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-\u03b3 level in Nod mice","volume":"6","author":"Krych","year":"2015","journal-title":"Gut Microbes"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3274-0","article-title":"Aberrant gut microbiota composition at the onset of type 1 diabetes in young children","volume":"57","author":"de Goffau","year":"2014","journal-title":"Diabetologia"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/nu7115461","article-title":"Diet, Microbiota and immune system in type 1 diabetes development and evolution","volume":"7","author":"Mej\u00eda-Le\u00f3n","year":"2015","journal-title":"Nutrients"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13140","article-title":"Gut microbiota of type 1 diabetes patients with good glycaemic control and high physical fitness is similar to people without diabetes: An observational study","volume":"34","author":"Stewart","year":"2016","journal-title":"Diabetic Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3043","article-title":"Gut microbiome in type 1 diabetes: A comprehensive review","volume":"34","author":"Zheng","year":"2018","journal-title":"Diabetes\/Metab Res Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00029","article-title":"Impact of gut microbiota on host glycemic control","volume":"10","author":"G\u00e9rard","year":"2019","journal-title":"Front Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"B20","first-page":"1","article-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","volume":"2","author":"Peterson","year":"2011","journal-title":"Ottawa: Ottawa Hosp Res Institute"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the newcastle-ottawa BSR20182348 scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14949","article-title":"MicroRNA expression in apical periodontitis and pulpal inflammation: A systematic review","volume":"11","author":"Al Gashaamy","year":"2023","journal-title":"PeerJ"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188475","article-title":"Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study","volume":"12","author":"de Groot","year":"2017","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01689","article-title":"Intestinal dysbiosis in autoimmune diabetes is correlated with poor glycemic control and increased interleukin-6: A pilot study","volume":"9","author":"Higuchi","year":"2018","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.04.032","article-title":"Gut microbiota profiling in Han chinese with type 1 diabetes","volume":"41","author":"Huang","year":"2018","journal-title":"Diabetes Research and Clinical Practice"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0253","article-title":"Gut microbiota differs in composition and functionality between children with type 1 diabetes and MODY2 and healthy control subjects: A case-control study","volume":"41","author":"Leiva-Gea","year":"2018","journal-title":"Diabetes Care"},{"key":"B27","doi-asserted-by":"publisher","first-page":"BSR20182348","DOI":"10.1042\/bsr20182348","article-title":"Gut microbiota imbalances in Tunisian participants with type 1 and type 2 diabetes mellitus","volume":"39","author":"Fassatoui","year":"2019","journal-title":"Biosci. Rep"},{"key":"B28","article-title":"The Gut Microbiome of Adults with Type 1 Diabetes and Its Association with the Host Glycemic Control","volume-title":"Diabetes Care","author":"Shilo","year":"2022"},{"key":"B29","author":"Rothschild","year":"2022"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-2225","article-title":"The gut microbiome composition is altered in long-standing type 1 diabetes and associates with glycemic control and disease-related complications","volume":"45","author":"van Heck","year":"2022","journal-title":"Diabetes Care"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1900\/RDS.2012.9.251","article-title":"Gut microbiota and Type 1 diabetes","volume-title":"Rev Diabet Stud","author":"Vaarala","year":"2012"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.05.013","article-title":"The gut microbiota and type 1 diabetes","volume":"159","author":"G\u00fclden","year":"2015","journal-title":"Clin Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13099-019-0332-7","article-title":"Is there any association between gut microbiota and type 1 diabetes? A systematic review","volume":"11","author":"Jamshidi","year":"2019","journal-title":"Gut Pathog"},{"key":"B34","doi-asserted-by":"publisher","first-page":"8291","DOI":"10.1038\/ismej.2010.92","article-title":"Toward defining the autoimmune microbiome for type 1 diabetes","volume":"5","author":"Giongo","year":"2010","journal-title":"ISME J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12866-022-02575-1","article-title":"Gut microbiota differs in composition between adults with type 1 diabetes with or without depression and healthy control participants: A case-control study","volume":"22","author":"Petrak","year":"2022","journal-title":"BMC Microbiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.182841","article-title":"Imbalance of fecal microbiota at newly diagnosed type 1 diabetes in Chinese children","volume":"129","author":"Qi","year":"2016","journal-title":"Chin Med J"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1033393","article-title":"High-risk genotypes for type 1 diabetes are associated with the imbalance of gut microbiome and serum metabolites","volume":"13","author":"Yue","year":"2022","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314650","article-title":"Pathophysiology of type 1 diabetes and gut microbiota role","volume":"23","author":"Del Chierico","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2021.02.007","article-title":"Regulation of intestinal barrier function by microbial metabolites","volume":"11","author":"Ghosh","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031105","article-title":"Gut microbiota and short chain fatty acids: implications in glucose homeostasis","volume":"23","author":"Portincasa","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2014.177","article-title":"Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula","volume":"9","author":"Xu","year":"2015","journal-title":"ISME J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9051098","article-title":"Akkermansia muciniphila, a new generation of beneficial microbiota in modulating obesity: A systematic review","volume":"9","author":"Abuqwider","year":"2021","journal-title":"Microorganisms"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0838.2007.00747.x","article-title":"Walking, vigorous physical activity, and markers of hemostasis and inflammation in healthy men and women","volume":"18","author":"Hamer","year":"2008","journal-title":"Scand. J Med Sci Sports"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2790","article-title":"Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes","volume":"32","author":"Maffeis","year":"2016","journal-title":"Diabetes\/Metab Res Rev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2015.01.001","article-title":"The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes","volume":"17","author":"Kostic","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1676","article-title":"Compromised gut microbiota networks in children with anti-islet cell autoimmunity","volume":"63","author":"Endesfelder","year":"2014","journal-title":"Diabetes"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00979","article-title":"Bifidobacteria and butyrate-producing colon bacteria: Importance and strategies for their stimulation in the human gut","volume":"7","author":"Rivi\u00e8re","year":"2016","journal-title":"Front Microbiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet\u2013induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/nu5030829","article-title":"The role of gut microbiota on insulin resistance","volume":"5","author":"Caricilli","year":"2013","journal-title":"Nutrients"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0791-0","article-title":"Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia","volume":"50","author":"Cani","year":"2007","journal-title":"Diabetologia"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1265696\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T08:13:42Z","timestamp":1700036022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1265696\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":52,"alternative-id":["10.3389\/fendo.2023.1265696"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1265696","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"article-number":"1265696"}}